Table of Content


Chapter 1. Global Vulvovaginal Candidiasis Treatment Market Executive Summary
1.1. Global Vulvovaginal Candidiasis Treatment Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
?1.3.1. By Drug Class
?1.3.2. By Disease Type
?1.3.3. By Route of Administration
?1.3.4. By Type
?1.3.5. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Vulvovaginal Candidiasis Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
?2.3.1. Inclusion & Exclusion
?2.3.2. Limitations
?2.3.3. Supply Side Analysis
??2.3.3.1. Availability
??2.3.3.2. Infrastructure
??2.3.3.3. Regulatory Environment
??2.3.3.4. Market Competition
??2.3.3.5. Economic Viability (Consumer’s Perspective)
?2.3.4. Demand Side Analysis
??2.3.4.1. Regulatory Frameworks
??2.3.4.2. Technological Advancements
??2.3.4.3. Environmental Considerations
??2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Vulvovaginal Candidiasis Treatment Market Dynamics
3.1. Market Drivers
?3.1.1. Rising Risk Factors (Diabetes, Antibiotic Overuse)
?3.1.2. Demand for Convenient, Patient-Centric Therapies
?3.1.3. Growth of E-Pharmacy and Self-Diagnosis Trends
3.2. Market Challenges
?3.2.1. Antifungal Resistance and Limited Novel Pipelines
?3.2.2. Diagnostic Complexities and Underreporting
3.3. Market Opportunities
?3.3.1. Regulatory Easing for OTC Antifungals
?3.3.2. Digital Health Interventions & Teleconsultation
?3.3.3. Innovative Intravaginal Delivery Systems
Chapter 4. Global Vulvovaginal Candidiasis Treatment Market Industry Analysis
4.1. Porter’s Five Forces Model
?4.1.1. Bargaining Power of Suppliers
?4.1.2. Bargaining Power of Buyers
?4.1.3. Threat of New Entrants
?4.1.4. Threat of Substitutes
?4.1.5. Competitive Rivalry
?4.1.6. Futuristic Adaptation of Porter’s Model
?4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
?4.2.1. Political
?4.2.2. Economic
?4.2.3. Social
?4.2.4. Technological
?4.2.5. Environmental
?4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Vulvovaginal Candidiasis Treatment Market Size & Forecasts by Drug Class (2022–2032)
5.1. Segment Dashboard
5.2. Fluconazole: Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.3. Clotrimazole: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 6. Global Vulvovaginal Candidiasis Treatment Market Size & Forecasts by Disease Type (2022–2032)
6.1. Segment Dashboard
6.2. Uncomplicated VVC: Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.3. Complicated VVC: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 7. Global Vulvovaginal Candidiasis Treatment Market Size & Forecasts by Route of Administration (2022–2032)
7.1. Segment Dashboard
7.2. Oral: Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.3. Topical: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 8. Global Vulvovaginal Candidiasis Treatment Market Size & Forecasts by Type (2022–2032)
8.1. Segment Dashboard
8.2. Prescription: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3. Over-the-Counter (OTC): Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 9. Global Vulvovaginal Candidiasis Treatment Market Size & Forecasts by Distribution Channel (2022–2032)
9.1. Segment Dashboard
9.2. Hospital Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.3. Retail Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.4. Online Pharmacies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
Chapter 10. Global Vulvovaginal Candidiasis Treatment Market Size & Forecasts by Region (2022–2032)
10.1. North America Market
?10.1.1. U.S. Market
?10.1.2. Canada Market
10.2. Europe Market
?10.2.1. UK Market
?10.2.2. Germany Market
?10.2.3. France Market
?10.2.4. Spain Market
?10.2.5. Italy Market
?10.2.6. Rest of Europe Market
10.3. Asia Pacific Market
?10.3.1. China Market
?10.3.2. India Market
?10.3.3. Japan Market
?10.3.4. Australia Market
?10.3.5. South Korea Market
?10.3.6. Rest of Asia Pacific Market
10.4. Latin America Market
?10.4.1. Brazil Market
?10.4.2. Mexico Market
10.5. Middle East & Africa Market
?10.5.1. Saudi Arabia Market
?10.5.2. South Africa Market
?10.5.3. Rest of Middle East & Africa Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
?11.1.1. Pfizer Inc.
?11.1.2. Bayer AG
?11.1.3. Novartis AG
11.2. Top Market Strategies
11.3. Company Profiles
?11.3.1. Pfizer Inc.
??11.3.1.1. Key Information
??11.3.1.2. Overview
??11.3.1.3. Financial (Subject to Data Availability)
??11.3.1.4. Product Summary
??11.3.1.5. Market Strategies
?11.3.2. Sanofi S.A.
?11.3.3. Mycovia Pharmaceuticals
?11.3.4. GlaxoSmithKline plc
?11.3.5. Perrigo Company plc
?11.3.6. Lupin Pharmaceuticals, Inc.
?11.3.7. Teva Pharmaceutical Industries Ltd.
?11.3.8. Cadila Healthcare Ltd.
?11.3.9. Astellas Pharma Inc.
?11.3.10. Sun Pharmaceutical Industries Ltd.
?11.3.11. Cipla Inc.
?11.3.12. Mylan N.V.
?11.3.13. Scynexis, Inc.
Chapter 12. Research Process
12.1. Research Process
?12.1.1. Data Mining
?12.1.2. Analysis
?12.1.3. Market Estimation
?12.1.4. Validation
?12.1.5. Publishing
12.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Vulvovaginal Candidiasis Treatment market, research methodology
FIG 2. Global market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Porter’s Five Forces model
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Market by Drug Class, 2022 & 2032 (USD Million)
FIG 10. Market by Disease Type, 2022 & 2032 (USD Million)
FIG 11. Market by Route of Administration, 2022 & 2032 (USD Million)
FIG 12. Market by Type, 2022 & 2032 (USD Million)
FIG 13. Market by Distribution Channel, 2022 & 2032 (USD Million)
FIG 14. Regional snapshot 2022 & 2032
FIG 15. North America market 2022 & 2032 (USD Million)
FIG 16. Europe market 2022 & 2032 (USD Million)
FIG 17. Asia Pacific market 2022 & 2032 (USD Million)
FIG 18. Latin America market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa market 2022 & 2032 (USD Million)
FIG 20. Antifungal resistance & novel therapies trends (2023)

List of Tables

List of Tables
TABLE 1. Global Vulvovaginal Candidiasis Treatment market, report scope
TABLE 2. Global Vulvovaginal Candidiasis Treatment market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Vulvovaginal Candidiasis Treatment market estimates & forecasts by Drug Class 2022–2032 (USD Million)
TABLE 4. Global Vulvovaginal Candidiasis Treatment market estimates & forecasts by Disease Type 2022–2032 (USD Million)
TABLE 5. Global Vulvovaginal Candidiasis Treatment market estimates & forecasts by Route of Administration 2022–2032 (USD Million)
TABLE 6. Global Vulvovaginal Candidiasis Treatment market estimates & forecasts by Type 2022–2032 (USD Million)
TABLE 7. Global Vulvovaginal Candidiasis Treatment market estimates & forecasts by Distribution Channel 2022–2032 (USD Million)
TABLE 8. Global Vulvovaginal Candidiasis Treatment market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Vulvovaginal Candidiasis Treatment market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. U.S. market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 11. Canada market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Canada market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 13. UK market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Germany market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. France market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. Spain market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Italy market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Asia Pacific market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Latin America market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Million)